(Q35181589)

7 August 2017

1 reference

title

Cardiovascular pharmacogenetics in the SNP era. (English)

1 reference

7 August 2017

Mooser V

1

1 reference

7 August 2017

Waterworth DM

series ordinal

2

1 reference

7 August 2017

Isenhour T

series ordinal

3

1 reference

7 August 2017

Middleton L

series ordinal

4

1 reference

7 August 2017

publication date

1 July 2003

1 reference

Journal of Thrombosis and Haemostasis

7 August 2017

published in

1 reference

7 August 2017

volume

1

1 reference

7 August 2017

issue

7

1 reference

7 August 2017

page(s)

1398-1402

1 reference

Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00272.X

Contribution of major diseases to disparities in mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00272.X

Trends and correlates of class 3 obesity in the United States from 1990 through 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00272.X

Prevalence and Trends in Obesity Among US Adults, 1999-2000

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00272.X

Cardiovascular diseases in the developing countries: dimensions, determinants, dynamics and directions for public health action

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00272.X

Pharmacogenomics: translating functional genomics into rational therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00272.X

The genetic basis of variability in drug responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00272.X

Pharmacogenetics and adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00272.X

Genome-based pharmacogenetics and the pharmaceutical industry

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00272.X

The management of hypertensive disease in black patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00272.X

Epithelial sodium channel and the control of sodium balance: interaction between genetic and environmental factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00272.X

High risk for hyperlipidemia and the metabolic syndrome after an episode of hypertriglyceridemia during 13-cis retinoic acid therapy for acne: a pharmacogenetic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00272.X

The APOE locus and the pharmacogenetics of lipid response

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00272.X

Genetic variations in HLA-B region and hypersensitivity reactions to abacavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00272.X

Medical applications of haplotype-based SNP maps: learning to walk before we run.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00272.X

Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00272.X

Intensely punctate meiotic recombination in the class II region of the major histocompatibility complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00272.X

The structure of haplotype blocks in the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00272.X

Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00272.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00272.X

Contribution of major cardiovascular risk factors to familial premature coronary artery disease: the GENECARD project

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00272.X

Pharmacogenetic approaches to hypertension therapy: design and rationale for the Genetics of Hypertension Associated Treatment (GenHAT) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00272.X

10.1046/J.1538-7836.2003.00272.X

21 January 2018

Identifiers

DOI

1 reference

7 August 2017

1 reference